Parkinson's Treatment in Cuba for U.S. Patients: Complete Guide

Why American Parkinson's Patients Choose Cuba

Nearly one million Americans are living with Parkinson's disease, with approximately 90,000 new diagnoses each year. While the U.S. offers excellent neurologists and medications, American Parkinson's care has a critical gap: intensive, coordinated, multidisciplinary rehabilitation is rarely available at the intensity needed to maximize function and slow decline.

In the U.S., Parkinson's patients typically see a neurologist every 3-6 months for medication management, and may receive physical therapy 1-2 times per week — if insurance authorizes it. The idea of 4-6 hours of daily therapy across physical, occupational, speech, and cognitive disciplines is virtually unheard of in standard American outpatient care.

Cuba's CIREN (International Center for Neurological Restoration) fills this gap with its 4-week intensive Parkinson's program. For American patients who want more than medication management — who want concentrated rehabilitation, neuroprotective research therapy (NeuroEPO), and a comprehensive approach to maintaining function — Cuba offers an alternative unavailable in the U.S. healthcare system.

NeuroEPO: Not Available in the United States

NeuroEPO is Cuba's neuroprotective research therapy — a recombinant erythropoietin formulation developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB) that is designed to cross the blood-brain barrier and deliver neuroprotective effects directly to brain tissue.

Critical information for U.S. patients: • NeuroEPO is NOT FDA-approved and is NOT available in the United States. • It is administered within research protocols at CIREN as part of a comprehensive treatment program. • Cuban clinical research has explored NeuroEPO's potential to protect dopaminergic neurons, reduce neuroinflammation, and support neuroplasticity in Parkinson's patients. • NeuroEPO is investigational — results vary by individual, and no outcome is guaranteed. • It is not a standalone treatment; it is integrated with intensive daily rehabilitation.

For American Parkinson's patients who have optimized their medication regimen but still experience progressive functional decline, NeuroEPO represents a research-based neuroprotective approach available exclusively in Cuba. SMC Salud provides transparent, honest information about what NeuroEPO can and cannot do, and each patient is individually evaluated by the CIREN medical team to determine suitability.

CIREN vs. U.S. Standard Parkinson's Care

The difference between CIREN's program and standard U.S. Parkinson's care is primarily one of intensity and coordination:

U.S. Standard Care: • Neurologist visit every 3-6 months for medication adjustment • Physical therapy 1-2x/week (if Medicare/insurance authorizes) • Occasional occupational or speech therapy • Exercise recommendations (patient manages independently) • Limited multidisciplinary coordination • No neuroprotective therapy options

CIREN's Intensive Program (4 weeks): • 4-6 hours of daily therapy, 5 days per week • Physical therapy (2-3 hours/day): gait training, balance, coordination, freezing management • Occupational therapy (1-2 hours/day): daily living skills, fine motor, home modification guidance • Speech therapy: voice training (LSVT principles), swallowing, facial expression • Cognitive rehabilitation: attention, executive function, memory strategies • NeuroEPO neuroprotective therapy (research protocol) • Pharmacological optimization by neurologist • Multidisciplinary team case conferences • Caregiver education and training

This concentrated approach leverages neuroplasticity — the brain's ability to reorganize and form new neural connections. While U.S. therapy is limited by insurance authorizations and scheduling constraints, CIREN delivers the intensity that research suggests is necessary for meaningful functional improvement in Parkinson's.

Travel, Cost & Logistics for U.S. Patients

Travel from the U.S. to Cuba for medical treatment:

• Travel authorization — U.S. citizens can travel to Cuba under approved categories. SMC Salud provides documentation including letter of medical necessity and treatment confirmation to support travel compliance. Our team guides you through the entire process. • Flights — Direct charter flights from Miami, Tampa, and Fort Lauderdale to Havana (approx. 1 hour). Commercial connections via Mexico, Canada, or the Bahamas are also available. • Program duration — Parkinson's programs are typically 4 weeks. SMC Salud coordinates accommodation for the patient and accompanying family near CIREN in Havana. • English-speaking coordinators — Available throughout the stay for translation, support, and communication with family back home. • Telemedicine follow-up — After returning to the U.S., remote consultations with the Cuban neurology team help track progress and adjust the home exercise program.

Cost considerations for U.S. patients: • The CIREN program is all-inclusive: medical care + 4-6 hours daily therapy + NeuroEPO + accommodation + meals + coordination. • U.S. insurance and Medicare do NOT cover treatment in Cuba — patients pay out-of-pocket. • Payment via secure online gateway (Visa/MasterCard) or international bank transfer in EUR. • HSA/FSA funds may be usable — consult your plan administrator. • SMC Salud provides comprehensive medical documentation that patients can submit to insurance for potential reimbursement or for tax deduction purposes. • When compared to the cost of U.S. intensive rehabilitation (which can exceed $1,000/day at inpatient rehab facilities), CIREN's program is often more cost-effective for the level of intensive therapy provided.

After the program, patients receive a comprehensive medical report and a personalized home exercise program. The gains achieved during intensive rehabilitation must be maintained through regular exercise at home — and SMC Salud's coordinators remain available for ongoing support and telemedicine follow-up.